Index
Module 10 • Neurology
Neurocritical Care
68%
Data Tables
Neurocritical Care
Keaton S. Smetana ~2 min read Module 10 of 20
36
/ 53

Neurocritical Care

iv.

ASIA D: Incomplete, motor function is preserved below the neurological level of injury, and at

least half the key muscles below the injury level have a muscle grade of 3 or more (i.e., joints

can be moved against gravity)

ASIA E: Normal, motor and sensory functions are normal

C.Imaging (Neurosurgery 2013;60(suppl 1):82-91)
1

CT scan of spine

2Many views of spine radiography are necessary when a CT scan is unavailable.
D.Causes
1

40%โ€“50% are caused by motor vehicle collisions.

2Falls (20%), violence (14%), recreational and work activities
E.Clinical Impact
1

Mortality

50%โ€“75% at the time of injury

Hospital mortality 4.4%โ€“16%

2Morbidity

Paralysis and loss of sensation

Spasticity

Orthostatic hypotension

d.Autonomic dysreflexia

VTE

Decubitus ulcers

Respiratory insufficiency

Bowel and bladder dysfunction

Sexual dysfunction

Treatment considerations

k.Neurogenic shock

Hypotension often occurs after injury (50%โ€“90% of cervical spine injuries).

ii.

May be associated with malperfusion of the spinal cord and worsened outcomes

iii.

Etiology of shock is decreased sympathetic nervous system outflow. Continues to be

counterbalanced by parasympathetic outflow, which is not affected by SCI

iv.

Results in hypotension and bradycardia

F.

Blood Pressure Management

1

Typical recommendations after an acute SCI are to maintain MAP 85โ€“90 mm Hg for 7 days to ensure

adequate spinal perfusion.

2Little high-quality evidence supports this recommendation, but the recommendation is included in the

SCI guidelines as a treatment option.

3

Often requires judicious fluid resuscitation and vasopressor support

4

Persistent hypotension may be treated with fludrocortisone or midodrine.

5

Persistent bradycardia may be treated with pseudoephedrine or low-dose theophylline.

6

Droxidopa, an enteral analog of norepinephrine, may be useful for blood pressure augmentation in this

setting.

G.VTE Prophylaxis
1

VTE occurs in 80%โ€“100% of patients without pharmacologic prophylaxis

HD Video Explanation โ€” Synchronized with PDF
Starts at: minute 35 Open on YouTube